Related Experiment Video
Updated: Sep 13, 2025

The 5-Choice Serial Reaction Time Task: A Task of Attention and Impulse Control for Rodents
Published on: August 10, 2014
Low dose nicotine administration improves attentional performance in rats but is not blocked by nicotinic antagonists
Megan Stout1, Ella Andonov1, Amir H Rezvani1
1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:
Nicotine has been found by a variety of studies to improve cognitive function, including attention in both humans and experimental animals. However, it is not known which nicotinic acetylcholine receptor (nAChR) stimulating vs. desensitizing effects of nicotine are responsible for the cognitive improvement. Young adult female Sprague-Dawley rats were trained on an operant visual signal detection task to assess sustained attention. Then, they were administered nicotine subcutaneously (sc) in low doses of 0, 0.01, 0.02 or 0.04 mg/kg (N = 10-11/group), 20 min before the test sessions. In the next phase, nicotine or vehicle saline was given alone or in combination with doses of 4 and 8 mg/kg (sc) of dihydro-β-erythroidine (DHβE), an α4β2 nicotinic receptor antagonist or methyllycaconitine (MLA), an α7 nicotinic receptor antagonist, to determine whether any effects caused by nicotine would be blocked by co-administration of these nAChR antagonists. Our results show that both 0.01 mg/kg and 0.04 mg/kg nicotine doses caused modest, but significant improvement in percent correct on the attentional test relative to control rats, while the 0.02 mg/kg nicotine dose had a marginal (p < 0.10) improvement that did not reach statistical significance. The significant improvement in percent correct performance on the attention test continued to be evident during the second phase of the study in which nAChR antagonists were co-administered. The rats given 0.01 mg/kg of nicotine continued to show a significant improvement in percent correct relative to the saline vehicle even in the face of the higher dose of each nicotinic antagonist. Our results show that low dose nicotine-induced attentional performance was not reversed by specific nAChR antagonists such as DHβE and MLA. This is consistent with the hypothesis that the nAChR desensitizing effect of nicotine, with low dose of nicotine, rather than the receptor stimulatory effect of nicotine underlies its action of improving attentional performance.
More Related Videos
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
10:04Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Published on: October 29, 2012
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Drugs Acting on Autonomic Ganglia: Blockers
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...